| 000 | 01779 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513125846.0 | ||
| 264 | 0 | _c19971202 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0732-8893 | ||
| 024 | 7 |
_a10.1016/s0732-8893(97)00071-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchaadt, R D | |
| 245 | 0 | 0 |
_aSerum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid. _h[electronic resource] |
| 260 |
_bDiagnostic microbiology and infectious disease _cAug 1997 |
||
| 300 |
_a201-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAcetamides _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnterococcus faecalis _xdrug effects |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aOxazoles _xadministration & dosage |
| 650 | 0 | 4 | _aOxazolidinones |
| 650 | 0 | 4 |
_aPneumococcal Infections _xblood |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xblood |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
| 700 | 1 | _aBatts, D H | |
| 700 | 1 | _aDaley-Yates, P T | |
| 700 | 1 | _aPawsey, S D | |
| 700 | 1 | _aStalker, D J | |
| 700 | 1 | _aZurenko, G E | |
| 773 | 0 |
_tDiagnostic microbiology and infectious disease _gvol. 28 _gno. 4 _gp. 201-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0732-8893(97)00071-0 _zAvailable from publisher's website |
| 999 |
_c9300446 _d9300446 |
||